Literature DB >> 21536228

Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients.

Sazan Rasul1, Aysegul Ilhan, Marie Helene Reiter, Sabina Baumgartner-Parzer, Alexandra Kautzky-Willer.   

Abstract

BACKGROUND: Despite the effective role of adiponectin levels in the predisposition to type 2 diabetes mellitus, the potential impact of adiponectin in manifest type 2 diabetes is less studied.
OBJECTIVES: This study aimed to determine gender-specific differences regarding the relationship between adiponectin levels and metabolic parameters as well as sex hormones in elderly type 2 diabetics.
METHODS: Sixty-two elderly type 2 diabetic men (mean age 60 [9] years) and 38 postmenopausal type 2 diabetic women (mean age 64 [9] years) were evaluated in a cross-sectional study. Glycemic control, lipids, sex hormones, adiponectin, and anthropometric parameters were measured in all participants.
RESULTS: Serum adiponectin was higher in women than in men (P < 0.006). After controlling for age and body mass index, adiponectin concentrations showed a positive correlation with sex hormone-binding globulin and high-density lipoprotein levels (P < 0.001) and a negative correlation with glycated hemoglobin, homeostasis model assessment index for insulin resistance, glucose, C-peptide, and triglyceride levels (P < 0.05) in all patients. In men, adiponectin significantly correlated with serum levels of testosterone (r = 0.420; P < 0.002). In women, negative correlations were observed between adiponectin levels and the fatty liver index (r = -0.492; P < 0.006) and γ-glutamyltransferase (r = -0.432; P < 0.01).
CONCLUSIONS: High serum adiponectin is a feature of better metabolic control and lipid profile, whereas low adiponectin levels are associated with fatty liver disease in women and low testosterone levels in men with type 2 diabetes.
Copyright © 2011 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536228     DOI: 10.1016/j.genm.2011.01.004

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  5 in total

Review 1.  Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.

Authors:  Sazan Rasul; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Endocrine       Date:  2012-07-21       Impact factor: 3.633

Review 2.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.

Authors:  Alexandra Kautzky-Willer; Jürgen Harreiter; Giovanni Pacini
Journal:  Endocr Rev       Date:  2016-05-09       Impact factor: 19.871

3.  The Role of Adiponectin in the Resolution of Male-Obesity-Associated Secondary Hypogonadism after Metabolic Surgery and Its Impact on Cardiovascular Risk.

Authors:  Pilar Cobeta; Roberto Pariente; Alvaro Osorio; Marta Marchan; Marta Cuadrado-Ayuso; David Pestaña; Julio Galindo; José I Botella-Carretero
Journal:  Biomedicines       Date:  2022-08-17

4.  Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women.

Authors:  Filipa Mascarenhas-Melo; Daniela Marado; Filipe Palavra; José Sereno; Álvaro Coelho; Rui Pinto; Edite Teixeira-Lemos; Frederico Teixeira; Flávio Reis
Journal:  Cardiovasc Diabetol       Date:  2013-04-09       Impact factor: 9.951

5.  Correlation of Adiponectin With Testosterone in Patients With and Without Type 2 Diabetes and Erectile Dysfunction.

Authors:  Moustafa A Elsaied; Doaa Masallat; Ibrahim A Abdel-Hamid
Journal:  Am J Mens Health       Date:  2018-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.